AstraZeneca's Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for small cell lung cancer patients Medical Dialogues Bureau21 March 2020 9:00 AM ISTImfinzi confirmed a sustained overall survival benefit in the final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell...
FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer Medical Dialogues Bureau22 Nov 2019 12:25 PM IST"Atezolizumab is the first cancer immunotherapy to receive approval from DCGI in India for the first-line treatment of extensive-stage small-cell lung...
Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer Medical Dialogues Bureau8 Sept 2019 9:25 AM ISTNovartis is aiming to win approval for oral capmatinib as a first-line treatment for patients with metastatic MET exon14 skipping-mutated non-small...
Abbvie to record $4 billion impairment charges on Stemcentrx assets Medical Dialogues Bureau6 Jan 2019 9:00 AM ISTThe drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
